BACTIGUARD HOLDING AB Financials Bactiguard Holding AB
Equities
BACTI B
SE0005878741
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 68.8 SEK | +2.08% |
|
+1.47% | +11.33% |
| May. 14 | Bactiguard Holding Ab Appoints Thomas Von Koch as the Chairman of the Board of Directors | CI |
| Apr. 25 | Transcript : Bactiguard Holding AB, Q1 2024 Earnings Call, Apr 25, 2024 |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 3,869 | 2,166 | 2,411 | - | - |
| Enterprise Value (EV) 1 | 3,869 | 2,276 | 2,594 | 2,583 | 2,537 |
| P/E ratio | -73.1 x | -15.6 x | -40.5 x | -130 x | 52.1 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | - | 9.7 x | 10.8 x | 10.1 x | 7.9 x |
| EV / Revenue | - | 10.2 x | 11.7 x | 10.8 x | 8.32 x |
| EV / EBITDA | - | -29.9 x | -451 x | 63.9 x | 28.8 x |
| EV / FCF | - | -38.2 x | -36 x | - | 66.8 x |
| FCF Yield | - | -2.62% | -2.78% | - | 1.5% |
| Price to Book | - | 6.13 x | 8.21 x | 8.77 x | 7.53 x |
| Nbr of stocks (in thousands) | 35,044 | 35,044 | 35,044 | - | - |
| Reference price 2 | 110.4 | 61.80 | 68.80 | 68.80 | 68.80 |
| Announcement Date | 2/9/23 | 2/8/24 | - | - | - |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net sales 1 | - | 223.2 | 222.4 | 238.5 | 305 |
| EBITDA 1 | - | -76.07 | -5.75 | 40.45 | 88 |
| EBIT 1 | - | -131.9 | -51.65 | -3.55 | 62 |
| Operating Margin | - | -59.12% | -23.23% | -1.49% | 20.33% |
| Earnings before Tax (EBT) 1 | - | -147.2 | -64.56 | -19.55 | 49 |
| Net income 1 | -52.88 | -138.4 | -59.62 | -18.58 | 46 |
| Net margin | - | -62.01% | -26.81% | -7.79% | 15.08% |
| EPS 2 | -1.510 | -3.950 | -1.700 | -0.5300 | 1.320 |
| Free Cash Flow 1 | - | -59.52 | -72 | - | 38 |
| FCF margin | - | -26.67% | -32.38% | - | 12.46% |
| FCF Conversion (EBITDA) | - | - | - | - | 43.18% |
| FCF Conversion (Net income) | - | - | - | - | 82.61% |
| Dividend per Share 2 | - | - | - | - | - |
| Announcement Date | 2/9/23 | 2/8/24 | - | - | - |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|
| Net sales 1 | 58.79 | 53 | 54 | 57 |
| EBITDA 1 | -1.501 | -6 | -2 | 4 |
| EBIT 1 | -12.87 | -18 | -14 | -8 |
| Operating Margin | -21.89% | -33.96% | -25.93% | -14.04% |
| Earnings before Tax (EBT) 1 | -12.2 | -22 | -18 | -12 |
| Net income 1 | -9.901 | -21 | -17 | -12 |
| Net margin | -16.84% | -39.62% | -31.48% | -21.05% |
| EPS 2 | -0.2800 | -0.6000 | -0.5000 | -0.3300 |
| Dividend per Share | - | - | - | - |
| Announcement Date | 4/25/24 | - | - | - |
1SEK in Million2SEK
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Debt 1 | - | 110 | 183 | 172 | 126 |
| Net Cash position 1 | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | -1.445 x | -31.78 x | 4.261 x | 1.432 x |
| Free Cash Flow 1 | - | -59.5 | -72 | - | 38 |
| ROE (net income / shareholders' equity) | - | -32.6% | -18.5% | -6.37% | 15.6% |
| ROA (Net income/ Total Assets) | - | - | - | - | - |
| Assets 1 | - | - | - | - | - |
| Book Value Per Share 2 | - | 10.10 | 8.380 | 7.850 | 9.140 |
| Cash Flow per Share | - | - | - | - | - |
| Capex 1 | - | 7.19 | 12 | 10 | 12 |
| Capex / Sales | - | 3.22% | 5.4% | 4.19% | 3.93% |
| Announcement Date | 2/9/23 | 2/8/24 | - | - | - |
1SEK in Million2SEK
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C-
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +11.33% | 229M | |
| +12.88% | 28.64B | |
| +23.84% | 2.59B | |
| +25.93% | 2.49B | |
| -46.39% | 2.39B | |
| -30.42% | 2.09B | |
| +32.22% | 2.04B | |
| -22.93% | 1.63B | |
| +14.34% | 1.45B | |
| +31.89% | 1.33B |
- Stock Market
- Equities
- BACTI B Stock
- Financials Bactiguard Holding AB
